Free Trial

Cardlytics (CDLX) Competitors

$8.45
+0.03 (+0.36%)
(As of 07/19/2024 ET)

CDLX vs. HCAT, EB, VNET, SABR, SVMK, IAS, AILE, TWKS, BLND, and SCWX

Should you be buying Cardlytics stock or one of its competitors? The main competitors of Cardlytics include Health Catalyst (HCAT), Eventbrite (EB), VNET Group (VNET), Sabre (SABR), SVMK (SVMK), Integral Ad Science (IAS), iLearningEngines (AILE), Thoughtworks (TWKS), Blend Labs (BLND), and SecureWorks (SCWX).

Cardlytics vs.

Cardlytics (NASDAQ:CDLX) and Health Catalyst (NASDAQ:HCAT) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, community ranking, analyst recommendations, valuation, media sentiment and institutional ownership.

Health Catalyst has lower revenue, but higher earnings than Cardlytics. Health Catalyst is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardlytics$309.20M1.33-$134.70M-$4.42-1.91
Health Catalyst$295.94M1.45-$118.15M-$1.85-3.92

Cardlytics has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500.

Cardlytics currently has a consensus price target of $12.67, indicating a potential upside of 49.90%. Health Catalyst has a consensus price target of $11.91, indicating a potential upside of 64.04%. Given Health Catalyst's higher possible upside, analysts plainly believe Health Catalyst is more favorable than Cardlytics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardlytics
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
Health Catalyst
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

Cardlytics received 74 more outperform votes than Health Catalyst when rated by MarketBeat users. However, 68.04% of users gave Health Catalyst an outperform vote while only 58.38% of users gave Cardlytics an outperform vote.

CompanyUnderperformOutperform
CardlyticsOutperform Votes
223
58.38%
Underperform Votes
159
41.62%
Health CatalystOutperform Votes
149
68.04%
Underperform Votes
70
31.96%

Health Catalyst has a net margin of -35.56% compared to Cardlytics' net margin of -55.23%. Health Catalyst's return on equity of -11.86% beat Cardlytics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardlytics-55.23% -25.36% -8.37%
Health Catalyst -35.56%-11.86%-6.26%

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 4.4% of Cardlytics shares are owned by insiders. Comparatively, 2.7% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Health Catalyst had 7 more articles in the media than Cardlytics. MarketBeat recorded 7 mentions for Health Catalyst and 0 mentions for Cardlytics. Cardlytics' average media sentiment score of 1.34 beat Health Catalyst's score of 0.80 indicating that Cardlytics is being referred to more favorably in the media.

Company Overall Sentiment
Cardlytics Positive
Health Catalyst Positive

Summary

Health Catalyst beats Cardlytics on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDLX vs. The Competition

MetricCardlyticsComputer & Data IndustryBusiness SectorNASDAQ Exchange
Market Cap$412.22M$75.79B$6.65B$8.41B
Dividend YieldN/A0.60%2.75%3.96%
P/E Ratio-1.9145.6317.3614.81
Price / Sales1.331,091.101,127.3578.85
Price / Cash6.7329.6127.9133.62
Price / Book2.464.024.514.42
Net Income-$134.70M$2.47B$117.39M$216.15M
7 Day Performance5.89%-0.58%0.11%-0.11%
1 Month Performance5.10%6.72%3.27%5.51%
1 Year Performance-3.43%5.57%1.81%1.70%

Cardlytics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCAT
Health Catalyst
4.1662 of 5 stars
4.17 / 5 stars
$7.35
+12.9%
$11.91
+62.0%
-42.2%$433.87M$295.94M-3.971,300Short Interest ↑
News Coverage
EB
Eventbrite
4.2929 of 5 stars
4.29 / 5 stars
$5.70
+22.8%
$9.93
+74.2%
-50.2%$553.53M$326.13M-30.00866Analyst Forecast
News Coverage
High Trading Volume
VNET
VNET Group
2.3913 of 5 stars
2.39 / 5 stars
$2.24
+3.2%
$2.85
+27.2%
-19.3%$576.58M$1.04B-0.853,038Analyst Upgrade
SABR
Sabre
2.2245 of 5 stars
2.22 / 5 stars
$3.40
+8.6%
$4.13
+21.3%
-14.2%$1.30B$2.91B-2.346,232News Coverage
SVMK
SVMK
0 of 5 stars
0.00 / 5 stars
N/AN/AN/A$1.38B$375.61M-14.541,367High Trading Volume
IAS
Integral Ad Science
2.7171 of 5 stars
2.72 / 5 stars
$10.67
+2.6%
$16.77
+57.2%
-49.1%$1.71B$474.37M1,068.07760Gap Down
AILE
iLearningEngines
1.1919 of 5 stars
1.19 / 5 stars
$9.98
+5.1%
$19.50
+95.4%
N/A$1.34BN/A0.0098News Coverage
Positive News
TWKS
Thoughtworks
0.8291 of 5 stars
0.83 / 5 stars
$3.05
+9.3%
$4.52
+48.2%
-55.4%$984.88M$1.13B-10.5210,500
BLND
Blend Labs
1.2254 of 5 stars
1.23 / 5 stars
$3.22
+10.3%
$3.15
-2.0%
+141.9%$734.42M$154.46M-5.541,690News Coverage
Positive News
SCWX
SecureWorks
0.3312 of 5 stars
0.33 / 5 stars
$7.43
+3.8%
$7.08
-4.7%
-1.9%$656.81M$365.88M-7.011,516Positive News

Related Companies and Tools

This page (NASDAQ:CDLX) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners